Iovance Biotherapeutics, Inc. - Common Stock (NQ:IOVA)
2.790
-0.130
(-4.45%)
Streaming Delayed Price
Updated: 10:00 AM EDT, Jul 30, 2025
Add to My Watchlist
All News about Iovance Biotherapeutics, Inc. - Common Stock


Iovance Biotherapeutics Appoints Dan Kirby as Chief Commercial Officer
February 10, 2025
Via GlobeNewswire

What's Wrong With Iovance Biotherapeutics Stock?
January 30, 2025
Via The Motley Fool

Where Will Iovance Biotherapeutics Be in 5 Years?
January 29, 2025
Via The Motley Fool


Prediction: This Stock Will Beat the Market in 2025
December 12, 2024
Via The Motley Fool


Is Iovance Biotherapeutics Stock a Millionaire Maker?
November 27, 2024
Via The Motley Fool

Got $1,500? Buy Iovance Biotherapeutics Now and Don't Look Back
November 23, 2024
Via The Motley Fool




3 Mid-Cap Stocks That Could Take Off in 2025
January 09, 2025
Via The Motley Fool

Why Iovance Biotherapeutics Stock Zoomed More Than 5% Higher Today
January 02, 2025
Via The Motley Fool










2 Innovative Stocks That Could Deliver Outsize Returns
November 22, 2024
Via The Motley Fool

2 Top Biotech Stocks to Buy Now and Hold For 5 Years or More
November 16, 2024
Via The Motley Fool




Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.